Chromone Derivatives CM3a Potently Eradicate Staphylococcus aureus Biofilms by Inhibiting Cell Adherence

References

• Tong S, Davis JS, Eichenberger E, et al. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28(3):603–661. doi:10.1128/CMR.00134-1426016486
   PubMed Web of Science ®Google Scholar
• Del Pozo J. Biofilm-related disease. Expert Rev Anti Infect Ther. 2018;16(1):51–65. doi:10.1080/14787210.2018.141703629235402
   PubMed Web of Science ®Google Scholar
• Suresh M, Biswas R, Biswas L. An update on recent developments in the prevention and treatment of Staphylococcus aureus biofilms. Int j Med Microbiol. 2019;309(1):1–12. doi:10.1016/j.ijmm.2018.11.00230503373
   PubMed Web of Science ®Google Scholar
• Pinto R, Soares FA, Reis S, et al. Innovative strategies toward the disassembly of the EPS matrix in bacterial biofilms. Front Microbiol. 2020;11:952. doi:10.3389/fmicb.2020.0095232528433
   PubMed Web of Science ®Google Scholar
• Lister J, Horswill A. Staphylococcus aureus biofilms: recent developments in biofilm dispersal. Front Cell Infect Microbiol. 2014;4:178. doi:10.3389/fcimb.2014.0017825566513
   PubMed Web of Science ®Google Scholar
• Grecka K, Xiong ZR, Chen H, et al. Effect of Ethanol Extracts of Propolis (EEPs) against staphylococcal biofilm-microscopic studies. Pathogens. 2020;9:8.
   Web of Science ®Google Scholar
• Del Pozo J, Patel R. The challenge of treating biofilm-associated bacterial infections. Clin Pharmacol Ther. 2007;82(2):204–209. doi:10.1038/sj.clpt.610024717538551
   PubMed Web of Science ®Google Scholar
• Conlon B. Staphylococcus aureus chronic and relapsing infections: evidence of a role for persister cells: an investigation of persister cells, their formation and their role in S. aureus disease. BioEssays: news and reviews in molecular. Cell Dev Biol. 2014;36(10):991–996.
   Google Scholar
• Savage V, Chopra I, O’Neill A. Staphylococcus aureus biofilms promote horizontal transfer of antibiotic resistance. Antimicrob Agents Chemother. 2013;57(4):1968–1970. doi:10.1128/AAC.02008-1223357771
   PubMed Web of Science ®Google Scholar
• Hoque J, Konai MM, Gonuguntla S, et al. Membrane active small molecules show selective broad spectrum antibacterial activity with no detectable resistance and eradicate biofilms. J Med Chem. 2015;58(14):5486–5500. doi:10.1021/acs.jmedchem.5b0044326102297
   PubMed Web of Science ®Google Scholar
• Mohsin N, Irfan M, Hassan SU. et al. Current strategies in development of new chromone derivatives with diversified pharmacological activities: a review. Pharm Chem j;2020. 1–17. doi:10.1007/s11094-020-02187-x32836513
   PubMed Web of Science ®Google Scholar
• Legoabe L, Petzer A, Petzer J. Inhibition of monoamine oxidase by selected C6-substituted chromone derivatives. Eur J Med Chem. 2012;49:343–353. doi:10.1016/j.ejmech.2012.01.03722309913
   PubMed Web of Science ®Google Scholar
• Yadav P, Parshad B, Manchanda P, et al. Chromones and their derivatives as radical scavengers: a remedy for cell impairment. Curr Top Med Chem. 2014;14(22):2552–2575. doi:10.2174/156802661466614120314131725478881
   PubMed Web of Science ®Google Scholar
• Matos M, Vazquez-Rodriguez S, Uriarte E, et al. Synthesis and pharmacological activities of non-flavonoid chromones: a patent review (from 2005 to 2015). Expert Opin Ther Pat. 2015;25(11):1285–1304. doi:10.1517/13543776.2015.107879026291463
   PubMed Web of Science ®Google Scholar
• Lahnsteiner M, Kastner A, Mayr J, et al. Improving the stability of maleimide-thiol conjugation for drug targeting. Chemistry. 2020;26(68):15867–15870. doi:10.1002/chem.20200395132871016
   PubMed Web of Science ®Google Scholar
• Sun X, Lin Z-W, Hu -X-X, et al. Biofilm formation in erythromycin-resistant Staphylococcus aureus and the relationship with antimicrobial susceptibility and molecular characteristics. Microb Pathog. 2018;124:47–53. doi:10.1016/j.micpath.2018.08.02130118805
   PubMed Web of Science ®Google Scholar
• CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 30th. 2020CLSI. CLSI supplement M100 Wayne PA: Clinical and Laboratory Standard Institute; 2018. Vol. 2018. 320.
   Google Scholar
• Zheng J, Sun X, Lin ZW, et al. In vitro activities of daptomycin combined with fosfomycin or rifampin on planktonic and adherent linezolid-resistant isolates of Enterococcus faecalis. J Med Microbiol. 2019;68(3):493–502. doi:10.1099/jmm.0.00094530882300
   PubMed Web of Science ®Google Scholar
• Bortolin M, Vecchi E, Romanò CL, et al. Antibiofilm agents against MDR bacterial strains: is bioactive glass BAG-S53P4 also effective? J Antimicrob Chemother. 2016;71(1):123–127. doi:10.1093/jac/dkv32726462989
   PubMed Web of Science ®Google Scholar
• Li Y, Wang R, Xue L, et al. Astilbin protects against cerebral ischaemia/reperfusion injury by inhibiting cellular apoptosis and ROS-NLRP3 inflammasome axis activation. Int Immunopharmacol. 2020;84:106571.32413740
   PubMed Web of Science ®Google Scholar
• Donlan R, Costerton J. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15(2):167–193. doi:10.1128/CMR.15.2.167-193.200211932229
   PubMed Web of Science ®Google Scholar
• Fisher R, Gollan B, Helaine S. Persistent bacterial infections and persister cells. Nat Rev Microbiol. 2017;15(8):453–464. doi:10.1038/nrmicro.2017.4228529326
   PubMed Web of Science ®Google Scholar
• Jin Y, Guo Y, Zhan Q, et al. Subinhibitory concentrations of mupirocin stimulate staphylococcus aureus biofilm formation by upregulating cidA. Antimicrob Agents Chemother. 2020;64(3):3. doi:10.1128/AAC.01912-19
   Web of Science ®Google Scholar
• Yu W, Hallinen K, Wood K. Interplay between antibiotic efficacy and drug-induced lysis underlies enhanced biofilm formation at subinhibitory drug concentrations. Antimicrob Agents Chemother. 2018;62:1.
   Web of Science ®Google Scholar
• Keri R, Budagumpi S, Pai RK, et al. Chromones as a privileged scaffold in drug discovery: a review. Eur J Med Chem. 2014;78:340–374. doi:10.1016/j.ejmech.2014.03.04724691058
   PubMed Web of Science ®Google Scholar
• Reis J, Gaspar A, Milhazes N, et al. Chromone as a privileged scaffold in drug discovery: recent advances. J Med Chem. 2017;60(19):7941–7957. doi:10.1021/acs.jmedchem.6b0172028537720
   PubMed Web of Science ®Google Scholar
• Park J, Lee SU, Kim SH, et al. Chromone and chromanone derivatives as strand transfer inhibitors of HIV-1 integrase. Arch Pharm Res. 2008;31(1):1–5. doi:10.1007/s12272-008-1111-z18277599
   PubMed Web of Science ®Google Scholar